Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for NeuroPace (NPCE) over the last 6 years, with Q3 2025 value amounting to -$48000.0.

  • NeuroPace's Change in Account Payables rose 6307.69% to -$48000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 15477.44%. This contributed to the annual value of $671000.0 for FY2024, which is 17958.33% up from last year.
  • Per NeuroPace's latest filing, its Change in Account Payables stood at -$48000.0 for Q3 2025, which was up 6307.69% from $737000.0 recorded in Q2 2025.
  • Over the past 5 years, NeuroPace's Change in Account Payables peaked at $1.1 million during Q4 2023, and registered a low of -$922000.0 during Q2 2024.
  • For the 5-year period, NeuroPace's Change in Account Payables averaged around $194315.8, with its median value being $191000.0 (2021).
  • Over the last 5 years, NeuroPace's Change in Account Payables had its largest YoY gain of 59222.8% in 2024, and its largest YoY loss of 409090.91% in 2024.
  • Over the past 5 years, NeuroPace's Change in Account Payables (Quarter) stood at $220000.0 in 2021, then soared by 288.64% to $855000.0 in 2022, then increased by 23.39% to $1.1 million in 2023, then decreased by 26.73% to $773000.0 in 2024, then tumbled by 106.21% to -$48000.0 in 2025.
  • Its Change in Account Payables was -$48000.0 in Q3 2025, compared to $737000.0 in Q2 2025 and $966000.0 in Q1 2025.